Theradiag

Theradiag Dividend Coverage

Dividend Coverage Ratio of Theradiag (ALTER.PA) as of Nov 11, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Theradiag is 2026 - . Dividend Coverage Ratio of Theradiag was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Theradiag Stock analysis

What does Theradiag do? Theradiag SA is a French company specialized in the development, production, and marketing of diagnostics for personalized medicine. The company was founded in 1986 and is headquartered in Marne-la-Vallée, France. It is listed on the stock exchange and belongs to the Euronext Growth market segment. Theradiag offers diagnostics for autoimmune, infectious, cancer, and inflammatory diseases. Its business model involves developing innovative diagnostics and selling them to clinical laboratories and hospitals. The company has a network of distributors to sell its products globally. Its offerings include diagnostics for autoimmune diseases, infections, cancer, and inflammation, as well as personalized medicine. The company invests in research and development to improve patients' health and well-being. Theradiag is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Theradiag stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Theradiag since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Theradiag historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Theradiag

All Key Metrics — Theradiag